| 摘要 |
This invention relates to: (a) compounds and salts thereof that, inter alia , inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. |
| 申请人 |
ABBVIE BAHAMAS LTD. |
发明人 |
FLENTGE, CHARLES, A. CA;HUTCHINSON, DOUGLAS, K. DK;BETEBENNER, DAVID, A. DA;DEGOEY, DAVID, A. DA;DONNER, PAMELA, L. PL;KATI, WARREN, M. WM;KRUEGER, ALLAN, C. AC;LIU, DACHUN D;LIU, YAYA Y;LONGENECKER, KENTON, L. KL;MARING, CLARENCE, J. CJ;MOTTER, CHRISTOPHER, E. CE;PRATT, JOHN, K. JK;RANDOLPH, JOHN, T. JT;ROCKWAY, TODD, W. TW;STEWART, KENT, D. KD;WAGNER, ROLF R;BARNES, DAVID, M. DM;CHEN, SHUANG S;FRANCZYK, THADDEUS, S., II TS;GAO, YI Y;HAIGHT, ANTHONY, R. AR;HENGEVELD, JOHN, E. JE;KOTECKI, BRIAN, J. BJ;LOU, XIAOCHUN X;ZHANG, GEOFF, G., Z. GGZ |
